INFLUENCE OF CO-DERGOCRINE MESILATE NIFEDIPINE COMPARED TO MEFRUSIDE NIFEDIPINE ON CIRCADIAN BLOOD-PRESSURE IN PATIENTS WITH ESSENTIAL-HYPERTENSION

被引：0

|

作者：

KIRSTEN, R

HELLER, A

HEINTZ, B

NELSON, K

机构：

来源：

JOURNAL OF HUMAN HYPERTENSION | 1990年 / 4卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

收藏

页码：461 / 464

页数：4

相关论文

共 50 条

[1] COMBINATION OF NIFEDIPINE AND CARTEOLOL COMPARED TO NIFEDIPINE ALONE IN DIURNAL BLOOD-PRESSURE VARIATION AND EXERCISE BLOOD-PRESSURE IN PATIENTS WITH ESSENTIAL-HYPERTENSION
INOUE, I
MATSUURA, H
FUJII, T
ISHIDA, T
OZONO, R
KAINOUCHI, M
TSUCHIOKA, Y
KAJIYAMA, G
[J]. CLINICAL THERAPEUTICS, 1992, 14 (01) : 22 - 29
[2] CO-DERGOCRINE MESYLATE INHIBITS THE INCREASE IN PLASMA-CATECHOLAMINES CAUSED BY NIFEDIPINE IN ESSENTIAL-HYPERTENSION
KIRSTEN, R
NELSON, K
WEIDINGER, G
WELZEL, D
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 39 (05) : 435 - 439
[3] SLOW-RELEASE NIFEDIPINE - EFFECT ON THE CIRCADIAN-RHYTHM OF BLOOD-PRESSURE IN ESSENTIAL-HYPERTENSION
PORTALUPPI, F
UBERTI, E
STROZZI, C
MARGUTTI, A
MONTANARI, L
RAMBALDI, R
TRASFORINI, G
PANSINI, R
[J]. ACTA CARDIOLOGICA, 1987, 42 (01) : 37 - 47
[4] METABOLIC CHANGES DURING CHRONIC ANTIHYPERTENSIVE TREATMENT WITH CO-DERGOCRINE MESILATE NIFEDIPINE IN ADVANCED AGE
RITTER, MM
RICHTER, WO
SCHWANDT, P
[J]. ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1992, 42-1 (03): : 311 - 313
[5] THE TOLERABILITY OF NILVADIPINE COMPARED TO NIFEDIPINE IN PATIENTS WITH ESSENTIAL-HYPERTENSION
FAUST, G
[J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 20 : S56 - S61
[6] INFLUENCE OF CO-DERGOCRINE MESILATE ON THE FILTERABILITY OF HYPEROSMOLAR BLOOD INVITRO
EHRLY, AM
SAEGERLORENZ, K
[J]. ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1992, 42-2 (08): : 1009 - 1011
[7] VERAPAMIL COMPARED WITH NIFEDIPINE IN THE TREATMENT OF ESSENTIAL-HYPERTENSION
MIDTBO, K
HALS, O
VANDERMEER, J
[J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1982, 4 : S363 - S368
[8] EFFECT OF NIFEDIPINE AND PROPRANOLOL ON BLOOD-FLOW, VENOUS COMPLIANCE AND BLOOD-PRESSURE IN ESSENTIAL-HYPERTENSION
OGILVIE, RI
[J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 1985, 132 (10) : 1137 - 1141
[9] CARDIOVASCULAR REGULATION AND LIPOPROTEIN PROFILE DURING ADMINISTRATION OF CO-DERGOCRINE IN ESSENTIAL-HYPERTENSION
UEHLINGER, DE
WEIDMANN, P
GNAEDINGER, MP
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 36 (02) : 119 - 125
[10] CO-DERGOCRINE PLASMA-CONCENTRATIONS AND BLOOD-PRESSURE CHANGES IN HYPERTENSIVE PATIENTS DURING THERAPY WITH SLOW-RELEASE CO-DERGOCRINE MESYLATE
WOODCOCK, BG
HERRMANN, W
HABEDANK, WD
[J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1992, 30 (02) : 63 - 65

← 1 2 3 4 5 →